
Guardant, PathGroup Partner to Expand Shield Blood Test Across 250+ Hospitals in 25 States
Guardant Health Partners with PathGroup to Expand Access to Shield™ Blood Test for Early Cancer Detection Across 25 States Guardant Health, Inc. (Nasdaq: GH), a pioneer in precision oncology, has…












